I-Paclitaxel Polymeric Micelles yokudluliselwa kobugcisa

Inkcazelo emfutshane:

I-Paclitaxel Polymeric Micelles lulungiselelo lwamva nje lwe-taxol, iteknoloji entsha edibanisa i-nanotechnology kunye ne-biomedical polymer material synthesis technology.Olu qulunqo lunamandla kakhulu kwi-vivo uzinzo kunye novakalelo oluphezulu lokukhutshwa kwechiza kwi-tumor. iimicelles zinokhuseleko olungcono xa idosi yeklinikhi yonyuswe kakhulu, kwaye akukho nyango lwangaphambili lwe-anti allergic lufunekayo phambi kokusetyenziswa.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Izinto ezilungileyo ze-paclitaxel polymer micelles

I-1.I-copolymer ihlangene ngokwayo emanzini ukuze yenze i-nanocarrier ene-"core-shell" structure.I-nuclear encapsulated paclitaxel ye-micelle ayithotywanga, ukwenzela ukuba ikwazi ukudlala indima yegazi ixesha elide.

I-polymer micellar paclitaxel particles zincinci kakhulu (18-20nm), ezinokujoliswa ngokuzimeleyo kwi-tumor microenvironment kunye nokuphazamiseka kwemithambo. Izicubu ze-tumor kunye noxinzelelo oluphantsi kwi-tissue eqhelekileyo.Ngelixa kuphuculwa ukusebenza kakuhle, izehlo zeziphumo ebezingalindelekanga ziyancipha ngakumbi.

Inkonzo yoTshintshiso lweTekhnoloji ye-Hande

IYunnan Hande Biotechnology Co.,Ltd ibigxile ekuveliseni i-paclitaxel API iminyaka engaphezu kwama-20, kwaye yenye yabavelisi behlabathi abazimeleyo be-paclitaxel API, ichiza elichasene nomhlaza eliphuma kwisityalo, elivunywe yi-US FDA, yaseYurophu. I-EDQM, i-TGA yase-Australia, i-CFDA yamaTshayina, i-Indiya, iJapan kunye nezinye ii-arhente ezilawulayo zelizwe. 18187887160.

Iinkonzo zethu

1.Iimveliso:Ukubonelela ngomgangatho ophezulu, izicatshulwa zezityalo ezisulungekileyo, imathiriyeli ekrwada yamayeza, kunye nabaphakathi bamayeza.

2.Iinkonzo zobugcisa:Izicatshulwa ezenziwe ngokwezifiso ezineenkcazo ezizodwa ngokweemfuno zabathengi.

Umzi-mveliso we-Hande

Yiba ngoyena mthengisi ubalaseleyo wezinto ezikrwada kunye namashishini anentembeko!

Wamkelekile ukuba uqhagamshelane nam ngokuthumela i-imeyile kumarketing@handebio.com


  • Ngaphambili:
  • Okulandelayo: